Session 114 - 12th CROI

Home

Session 114 Poster Abstracts
Pharmacology: Entry Inhibitors and P-Glycoprotein
Friday, 1:30 - 3:30 pm
Hall A

663	A Novel Probe Drug Interaction Study to Investigate the Effect of Selected ARV Combinations on the Pharmacokinetics of a Single Oral Dose of UK-427,857 in HIV + ve Subjects G Muirhead¹, Anton Pozniak*², B Gazzard², M Nelson², G Moyle², C Ridgway¹, R Taylor-Worth¹, and D Russell¹ ¹Pfizer Global Res and Devt, Sandwich, UK and ²Chelsea and Westminster Hosp, London, UK
664	The Pharmacokinetic Interaction between the CCR5 Antagonist 873140 and Lopinavir/Ritonavir in Healthy Subjects K Adkison, A Shachoy-Clark, L Fang, Y Lou, V Otto, M Berrey, and Stephen Piscitelli* GlaxoSmithKline, Research Triangle Park, NC, USA
665	Correlation between P-glycorotein and CXCR4 on PBMC and CD4+ Cells Isolated from HIV+ Individuals Becky Chandler*, S Khoo, M Detsikas, T Walsh, J Williams, D Back, and A Owen Univ of Liverpool, UK
666	P-glycoprotein and MRP1 Interactions with Rifampicin Ruben Hartkoorn*¹, C Waitt², M Chaponda², G Davies¹, B Chandler¹, A Owen¹, S Ward³, D Back¹, and S Khoo¹ ¹Univ of Liverpool, UK; ²Royal Liverpool Univ Hosp, UK; and ³Liverpool Sch of Tropical Med, UK
667	Racial Differences in Naive CD4⁺ Lymphocyte P-glycoprotein Activity Todd Hulgan*, J Donahue, R Kim, C Sutcliffe, B Lishawa, F Nicotera, R D'Aquila, S Raffanti, D Unutmaz, P Rebeiro, H Erdem, C Ingram, C Hawkins, and D Haas Vanderbilt Univ, Nashville, TN, USA